Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice
- 1 November 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 140 (5) , 831-838
Abstract
Little is known about the cellular effects induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy), although changes in gene expression have been observed following treatments with other psychostimulants. Thus, the aim of this study was to investigate in mice, the relationships between the ras‐dependent protein kinase ERK and MDMA‐induced reinforcement using the conditioned place preference (CPP) and locomotor activity measurements. This was completed using real‐time quantitative PCR method by a study of immediate early‐genes (IEGs) transcription known to be involved in neuronal plasticity. A significant CPP was observed after repeated MDMA treatment in CD‐1 mice at a dose of 9 mg kg−1 i.p. but not at 3 and 6 mg kg−1. This rewarding effect was abolished by the selective inhibitor of ERK activation, SL327 (50 mg kg−1; i.p.). Similar results were obtained on MDMA‐induced locomotor activity, clearly suggesting a role of ERK pathway in these behavioral responses. Following acute i.p. injection, MDMA induced a strong c‐fos transcription in brain structures, such as caudate putamen, nucleus accumbens and hippocampus, whereas egr‐1 and egr‐3 transcripts were only increased in the caudate putamen. MDMA‐induced IEGs transcription was selectively suppressed by SL327 in the caudate putamen, suggesting a role for other signaling pathways in regulation of IEGs transcription in the other brain structures. In agreement with these results, MDMA‐induced c‐fos protein expression was blocked by SL327 in the caudate putamen. This study confirms and extends to mice the reported role of ERK pathway in the development of addiction‐like properties of MDMA. This could facilitate studies about the molecular mechanism of this process by using mutant mice. British Journal of Pharmacology (2003) 140, 831–838. doi:10.1038/sj.bjp.0705506Keywords
This publication has 44 references indexed in Scilit:
- Integration of Signals from Receptor Tyrosine Kinases and G Protein-Coupled ReceptorsNeurosignals, 2002
- M1 Muscarinic Acetylcholine Receptors Activate Extracellular Signal-Regulated Kinase in CA1 Pyramidal Neurons in Mouse Hippocampal SlicesMolecular and Cellular Neuroscience, 2001
- Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectEuropean Journal of Neuroscience, 2001
- Effects of the Selective 5-HT2A Receptor Antagonist MDL 100,907 on MDMA-Induced Locomotor Stimulation in RatsNeuropsychopharmacology, 1996
- The role of dopamine in drug abuse viewed from the perspective of its role in motivationDrug and Alcohol Dependence, 1995
- Basal expression of the inducible transcription factors c‐Jun, JunB, JunD, c‐Fos, FosB, and Krox‐24 in the adult rat brainJournal of Comparative Neurology, 1995
- Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid toleranceBrain Research, 1994
- Drugs of abuse: anatomy, pharmacology and function of reward pathwaysTrends in Pharmacological Sciences, 1992
- MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preferencePharmacology Biochemistry and Behavior, 1991
- 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801European Journal of Pharmacology: Molecular Pharmacology, 1991